About
Shaun Holt is a life-sciences and diagnostics operator who serves as Chairman of the Board and Chief Executive Officer of Alveo Technologies. He is also an advisor to Celesta Capital; previously he was COO of Atonarp and CFO of Berkeley Lights, where he led the company through its $205 million IPO. Earlier in his career he held finance leadership roles at Illumina and now also serves on the board of Prellis Biologics.
Areas of interest
medtechlife sciencesmolecular diagnosticsbioconvergencepoint-of-need diagnosticsanimal healthsemiconductor and process sensing